Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: A population-based study

Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease

(2010) Oliver Riedel et al.   JOURNAL OF NEUROLOGY

Polypharmacy Correlates With Increased Risk for Hip Fracture in the Elderly

(2010) Shih-Wei Lai et al.   MEDICINE

Systematic Review of the Prevalence and Incidence of Parkinson’s Disease in Asia

(2009) Weerasak Muangpaisan et al.   JOURNAL OF EPIDEMIOLOGY

Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis

(2009) M M Wickremaratchi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Different Prevalence Rates of Parkinson’s Disease in Urban and Rural Areas: A Population-Based Study in Taiwan

(2009) Chih Chuan Chen et al.   NEUROEPIDEMIOLOGY

Characteristics of outpatient prescriptions for frail Taiwanese elders with long-term care needs

(2009) Ding-Cheng (Derrick) Chan et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Prevalence and incidence of Parkinsons disease in The Faroe Islands

(2008) L. Wermuth et al.   ACTA NEUROLOGICA SCANDINAVICA

Pesticide exposure and risk of Parkinson's disease: A family-based case-control study

(2008) Dana B Hancock et al.   BMC Neurology

Analysis of the association between polypharmacy and socioeconomic position among elderly aged ≥77 years in Sweden

(2008) Syed Imran Haider et al.   CLINICAL THERAPEUTICS

Risk Factors Associated with Adverse Drug Reactions Following Hospital Admission

(2008) Yurdaguel Zopf et al.   DRUG SAFETY

Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily

(2008) L. Morgante et al.   PARKINSONISM & RELATED DISORDERS